share_log

Wells Fargo Upgrades Integra Lifesciences to Overweight, Raises Price Target to $49

Benzinga ·  Dec 5, 2023 06:01

Wells Fargo analyst Larry Biegelsen upgrades Integra Lifesciences (NASDAQ:IART) from Equal-Weight to Overweight and raises the price target from $40 to $49.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment